Carole Huntsman's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 4,986 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 4,986 | 4,986 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 3,989 | 13,111 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 04 Mar 2026 | 419 | 12,692 (0%) | 0% | 431.9 | 180,983 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 494.59 per share. | 26 Jan 2026 | 570 | 9,122 (0%) | 0% | 494.6 | 281,916 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 492.42 per share. | 26 Jan 2026 | 340 | 9,692 (0%) | 0% | 492.4 | 167,423 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 550.97 per share. | 21 Nov 2025 | 894 | 11,096 (0%) | 0% | 551.0 | 492,567 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 559.60 per share. | 21 Nov 2025 | 200 | 10,232 (0%) | 0% | 559.6 | 111,920 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 552.38 per share. | 21 Nov 2025 | 200 | 10,592 (0%) | 0% | 552.4 | 110,477 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 547.27 per share. | 21 Nov 2025 | 144 | 10,952 (0%) | 0% | 547.3 | 78,807 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 556.04 per share. | 21 Nov 2025 | 120 | 10,432 (0%) | 0% | 556.0 | 66,725 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 548.71 per share. | 21 Nov 2025 | 120 | 10,832 (0%) | 0% | 548.7 | 65,845 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 560.62 per share. | 21 Nov 2025 | 80 | 10,152 (0%) | 0% | 560.6 | 44,850 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 564.56 per share. | 21 Nov 2025 | 80 | 10,032 (0%) | 0% | 564.6 | 45,165 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 563.20 per share. | 21 Nov 2025 | 40 | 10,112 (0%) | 0% | 563.2 | 22,528 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 553.22 per share. | 21 Nov 2025 | 40 | 10,552 (0%) | 0% | 553.2 | 22,129 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 549.35 per share. | 21 Nov 2025 | 40 | 10,792 (0%) | 0% | 549.4 | 21,974 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 5,703 | 5,703 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,386 | 11,990 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 335.00 per share. | 03 Mar 2025 | 563 | 8,604 (0%) | 0% | 335 | 188,605 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 320.21 per share. | 03 Mar 2025 | 300 | 9,867 (0%) | 0% | 320.2 | 96,063 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 314.74 per share. | 03 Mar 2025 | 200 | 10,167 (0%) | 0% | 314.7 | 62,948 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 324.59 per share. | 03 Mar 2025 | 200 | 9,467 (0%) | 0% | 324.6 | 64,918 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 323.65 per share. | 03 Mar 2025 | 200 | 9,667 (0%) | 0% | 323.7 | 64,730 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 329.64 per share. | 03 Mar 2025 | 100 | 9,167 (0%) | 0% | 329.6 | 32,964 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 327.49 per share. | 03 Mar 2025 | 100 | 9,267 (0%) | 0% | 327.5 | 32,749 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 326.34 per share. | 03 Mar 2025 | 100 | 9,367 (0%) | 0% | 326.3 | 32,634 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 313.08 per share. | 03 Mar 2025 | 71 | 10,367 (0%) | 0% | 313.1 | 22,229 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 347 | 10,438 (0%) | 0% | 335.2 | 116,328 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.92 per share. | 21 Nov 2024 | 688 | 10,785 (0%) | 0% | 316.9 | 218,041 | Common Stock |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 5,483 | 5,483 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Huntsman Carole | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 3,639 | 11,473 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 3,639 | 3,639 | - | - | Market Stock Unit |